PerkinElmer Acquires Covaris
SHELTON, Conn., Dec. 4, 2023 — PerkinElmer has acquired biotechnology company Covaris, in a move that PerkinElmer said will expand its existing life sciences portfolio into the high-growth diagnostics end market. Covaris is a developer of high-throughput genomic and proteomic analysis instruments, consumables, and reagents. Its solutions aim to enable research and drug discovery for clinical diagnostics, biopharma, and research markets globally. Terms of the transaction were not disclosed. According to Andre Moura,